SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-16-003875
Filing Date
2016-01-11
Accepted
2016-01-11 19:09:10
Documents
1
Period of Report
2016-01-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT almenoff-form4_010716.html 4  
1 OWNERSHIP DOCUMENT almenoff-form4_010716.xml 4 4005
  Complete submission text file 0001387131-16-003875.txt   5625
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Almenoff June Sherie (Reporting) CIK: 0001492647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 161337392